Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
REVTX-300 by Revelation Biosciences for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
REVTX-300 is under clinical development by Revelation Biosciences and currently in Phase I for Chronic Kidney Disease (Chronic Renal Failure)....